The Appeal Democrat: Mentions of the IRA in the Debate

By Julie Gill Shuffield, Patients Come First California Executive Director

The most recent presidential debate highlighted the plight of the rising costs of healthcare in the United States and the multitude of approaches our policymakers are taking to try and tackle the issue. President Harris pointed to the price controls negotiated under the Inflation Reduction Act as a good thing, but economists across the country have argued this policy is shortsighted and may have serious short and long-term effects on American’s medicine access. 

Following the debate, I saw an interesting article where entrepreneur Mark Cuban highlighted that cutting out drug middlemen may be a more sustainable way of lowering costs. This gives transparency and certainty to the costs of medicine without attempting to remove profit from those who boldly innovate and bring new drugs to market and transform lives. 

Read the full LTE here.